Search filters

List of works by Susan F Slovin

A Clinician's Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence [RADAR] III)

scientific article published on 01 April 2019

A Fully Synthetic Globo H Carbohydrate Vaccine Induces a Focused Humoral Response in Prostate Cancer Patients: A Proof of Principle

scientific article published on 01 February 1999

A Phase I Trial of IGF-1R Inhibitor Cixutumumab and mTOR Inhibitor Temsirolimus in Metastatic Castration-resistant Prostate Cancer

scientific article published on 11 January 2020

A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local Therapy

scientific article published on 4 April 2016

A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21

scientific article published on 01 May 2005

A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer

scientific article published on 14 November 2018

A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer ⬇️

scientific article published on December 13, 2012

A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer

scientific article published on 06 February 2019

A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors.

scientific article

A phase II trial of bortezomib and prednisone for castration resistant metastatic prostate cancer

scientific article published on 22 October 2007

A polyvalent vaccine for high-risk prostate patients: "are more antigens better?"

scientific article published on 10 July 2007

Adjuvant and salvage radiotherapy after prostatectomy: American Society of Clinical Oncology clinical practice guideline endorsement

scientific article

Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade

scientific article published on 01 April 2019

Androgen deprivation for minimal metastatic disease: threshold for achieving undetectable prostate-specific antigen

scientific article published on 01 May 2005

Anti-epidermal growth factor receptor monoclonal antibody cetuximab plus Doxorubicin in the treatment of metastatic castration-resistant prostate cancer

scientific article published on 01 October 2009

Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).

scientific article

Augmenting advance care planning in poor prognosis cancer with a video decision aid: a preintervention-postintervention study

scientific article

Carbohydrate vaccines as immunotherapy for cancer

scientific article

Challenges and recommendations for early identification of metastatic disease in prostate cancer

scientific article published on 08 January 2014

Chemotherapeutic response with single agent gemcitabine in metastatic Bellini duct tumor

scientific article published in January 2004

Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality

scientific article published in 2022

Clinical experience with intravenous estramustine phosphate, paclitaxel, and carboplatin in patients with castrate, metastatic prostate adenocarcinoma

scientific article published in November 2003

DNA vaccines: an active immunization strategy for prostate cancer

scientific article published on October 2003

Decision-making Processes among Prostate Cancer Survivors with Rising PSA Levels: Results from a Qualitative Analysis

scientific article published on 10 November 2014

Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research.

scientific article

Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival

scientific article

Dose escalation study of intravenous estramustine phosphate in combination with Paclitaxel and Carboplatin in patients with advanced prostate cancer.

scientific article published on June 2003

Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group

scientific article

Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications.

scientific article

Evolving understanding and categorization of prostate cancer: preventing progression to metastatic castration-resistant prostate cancer: RADAR IV

scientific article published on 01 October 2020

Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy.

scientific article

Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine

scientific article

HER-2 profiling and targeting in prostate carcinoma

scientific article published on 01 February 2002

Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer

scientific article

High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma

scientific article published in May 2004

Immunomodulatory Activity of a Colony-Stimulating Factor-1 Receptor Inhibitor in Patients With Advanced Refractory Breast or Prostate Cancer: A Phase 1 Study

scientific article published on 26 August 2020

Methylphenidate for fatigue in ambulatory men with prostate cancer

scientific article

Organoid cultures derived from patients with advanced prostate cancer

scientific article

Pharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer

scientific article published on 21 May 2019

Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer

scientific article published on 03 April 2009

Phase I dose-escalation study of the novel antiandrogen BMS-641988 in patients with castration-resistant prostate cancer

scientific article

Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors.

scientific article published on May 2007

Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancer.

scientific article

Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial

scientific article published on 22 October 2011

Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer

scientific article

Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer

scientific article published on 13 April 2009

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer

scientific article

Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancer

article

Phase I trial of the prostate-specific membrane antigen-directed immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancer

scientific article

Phase II study of cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortium

scientific article

Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer

scientific article

Pilot study of epothilone B analog (BMS-247550) and estramustine phosphate in patients with progressive metastatic prostate cancer following castration

scientific article published in October 2003

Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer.

scientific article published on October 2005

Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody

Platinum-Based Chemotherapy in Metastatic Prostate Cancer With DNA Repair Gene Alterations

scientific article published on 16 April 2020

Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making

scientific article published on 31 May 2017

Prostate Cancer National Summit's Call to Action

scientific article published on 16 April 2019

Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein

scientific article published on 30 September 2013

Rapid androgen cycling as treatment for patients with prostate cancer.

scientific article

Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer.

scientific article

Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy

scientific article published in October 2004

Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancer

scientific article

Second-line chemotherapy for prostate cancer: patient characteristics and survival

scientific article

Seizure Rates in Enzalutamide-Treated Men With Metastatic Castration-Resistant Prostate Cancer and Risk of Seizure: The UPWARD Study

scientific article

Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage

scientific article

Severe Hypocalcemia Associated With Denosumab in Metastatic Castration-Resistant Prostate Cancer: Risk Factors and Precautions for Treating Physicians.

scientific article published on 22 November 2014

Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer

scientific article

The Role of Therapeutic Layering in Optimizing Treatment for Patients With Castration-resistant Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence II).

scientific article

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma

scientific article published on 20 December 2016

Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer

scientific article published on 22 February 2005

Time to detectable metastatic disease in patients with rising prostate-specific antigen values following surgery or radiation therapy

scientific article published on 01 December 2005

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

scientific article

Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas

scientific article

Violaceous exanthem as a manifestation of metastatic prostate cancer in skin

scientific article published on 01 February 2006

Paulina is supported by:

About Paulina

Help